## [Fibronostics to Present LIVERFASt Data at DDW 2026](/content/fibronostics-to-present-liverfast-data-at-ddw-2026/index.html)

Fibronostics is pleased to share that Dr. Mona Munteanu, Chief Scientific Officer at Fibronostics, will be presenting new data on

## [Fibronostics to Present at MASH-TAG 2026 Conference](/content/fibronostics-at-mash-tag-2026-conference/index.html)

Fibronostics is excited to announce our participation in the MASH-TAG 2026 Conference, held from January 8-10, 2026, in beautiful Deer

## [Fibronostics Reaffirms Commitment to Quality with ISO 13485](/content/iso-13485/index.html)

At Fibronostics, our mission is built on a foundation of precision and trust. We are proud to announce that we

## [Fibronostics at AASLD Liver Meeting 2025](/content/fibronostics-at-aasld-liver-meeting/index.html)

Fibronostics is thrilled to announce its participation in the AASLD Liver Meeting 2025, the world’s leading conference dedicated to advancing

## [Fibronostics Acquires Stone Clinical Labs for MASH/MASLD Diagnostic Innovation](/content/fibronostics-completes-acquisition-of-stone-clinical-laboratories/index.html)

We’re excited to announce that Fibronostics has completed the acquisition of Stone Clinical Laboratories, LLC, a leading provider of advanced

## [Fibronostics Joins Experts in Liver Health at THASL 2025 Bangkok](/content/thasl-2025-fibronostics/index.html)

On June 11-13, Fibronostics had the privilege of participating in the THASL 2025 Annual Conference, hosted by the Thai Association

## [LIVERFASt (L-FAST) Identifies Advanced (F3F4, AF) and Clinically Significant Fibrosis (F2-F4, CSF) in MASLD Patients](/content/liverfast-l-fast-identifies-advanced-f3f4-af-and-clinically-significant-fibrosis-f2-f4-csf-in-masld-patients/index.html)

In a biopsy-validated cohort of MASLD patients (n=399, with 235 T2D), combining LIVERFASt with Fibroscan correctly identified 95% of F3–F4

## [Fibronostics to Exhibit at THASL 2025 Annual Conference in Bangkok](/content/fibronostics-at-thasl-2025-conference-in-bangkok/index.html)

Fibronostics is pleased to announce its participation in the THASL 2025 Annual Conference, hosted by the Thai Association for the Study of the

## [Fibronostics Achieves SOC 2 Compliance](/content/fibronostics-achieves-soc-2-compliance/index.html)

Fibronostics is now officially SOC 2 Type II compliant! This compliance reflects our deep commitment to keeping your data and

## [Fibronostics is ISO27001:2022 Certified Yet Again in 2025](/content/iso-27001-certified-in-2025/index.html)

We did it again! ­ Fibronostics is proud to announce that we have successfully renewed our ISO 27001:2022 certification for.